4//SEC Filing
Higgons John Duncan 4
Accession 0001640455-21-000040
CIK 0001640455other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:47 PM ET
Size
4.7 KB
Accession
0001640455-21-000040
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Sale
Common Stock
2021-02-16$11.78/sh−200$2,356→ 10,113 total
Footnotes (1)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2020. The Reporting Person exercised no discretion with respect to these transactions.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001581954
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:47 PM ET
- Size
- 4.7 KB